GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

High costs and limited access threaten progress in HIV treatment despite new drug advances, says GlobalData

Despite major strides in antiretroviral therapy (ART), the human immunodeficiency virus (HIV) market still faces serious challenges that threaten long-term control of the disease. The most pressing issue is the lack of affordable access to newer therapies, which—despite offering better adherence and fewer side effects—remain out of reach for many patients due to high costs […]
Read more

New CGM-enabled insulin delivery systems address demand for automated diabetes care, says GlobalData

With around 2 million Americans living with type 1 diabetes, and an increasing number of insulin-requiring type 2 cases, the US healthcare system is experiencing growing demand for simplified, automated diabetes care. The integration of Abbott Laboratories’ FreeStyle Libre 3 Plus continuous glucose monitor (CGM) with the Tandem t:slim X2 insulin pump system marks a […]
Read more

Tesla’s robotaxi fuels ride-hailing market hopes and social media buzz but safety questions loom, reveals GlobalData

Tesla’s much-anticipated robotaxi debut recently in Austin has sparked intense social media activity, blending enthusiasm with critical scrutiny. While early adopters praised the innovation and smooth user experience, concerns about safety and performance persist. Influencers are now driving conversations around Tesla’s potential to disrupt the ride-hailing market, comparing its cautious rollout to more mature autonomous […]
Read more
1 24 25 26 27 28 206